Sealong Biotechnology Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
492
- Latest Deal Type
-
PE Growth
- Latest Deal Amount
-
$32.2M
- Investors
-
5
Sealong Biotechnology General Information
Description
Provider of malic acid designed to use it for a wide range of applications. The company focuses on the development, production and sales of new materials, functional food additives and biodegradation, products such as malic acid are used to solve skin problems, enabling users to improve their lives.
Contact Information
Website
www.sealong.cnCorporate Office
- No. 6, Jinmin Road, Mohekou Industrial Park, Huaishang District
- Bengbu
- Bengbu, Anhui 233316
- China
Corporate Office
- No. 6, Jinmin Road, Mohekou Industrial Park, Huaishang District
- Bengbu
- Bengbu, Anhui 233316
- China
Sealong Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. PE Growth/Expansion | 25-Jan-2022 | $32.2M | Completed | Profitable | ||
| 4. Corporate | 21-Jul-2020 | Completed | Profitable | |||
| 3. PE Growth/Expansion | 30-Jul-2015 | Completed | Profitable | |||
| 2. IPO | 23-Jun-2014 | $7.18M | Completed | Profitable | ||
| 1. Later Stage VC | 08-Apr-2014 | $7.18M | $7.18M | Completed | Profitable |
Sealong Biotechnology Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Sealong Biotechnology Patents
Sealong Biotechnology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20140004560-A1 | Rhizopus oryzae strain, mutagenesis and screening methods thereof, and methods of fermenting to produce fumaric acid | Active | 24-Mar-2011 | ||
| US-8663972-B2 | Rhizopus oryzae strain, mutagenesis and screening methods thereof, and methods of fermenting to produce fumaric acid | Active | 24-Mar-2011 |
Sealong Biotechnology Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sealong Biotechnology Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Founder Hesheng Investment | Corporate Venture Capital | Minority | ||
| Anhui Fubo Pharmaceutical and Chemical | Corporation | Minority | ||
| Financial Street Securities | Investment Bank | Minority | ||
| Guoyuan Securities | PE/Buyout | Minority | ||
| Huaan Securities | Corporation | Minority |
Sealong Biotechnology Acquisitions (1)
Sealong Biotechnology’s most recent deal was a Merger/Acquisition with Langli Bio. The deal was made on 21-Aug-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Langli Bio | 21-Aug-2019 | Merger/Acquisition | Drug Discovery |
Sealong Biotechnology FAQs
-
When was Sealong Biotechnology founded?
Sealong Biotechnology was founded in 2007.
-
Where is Sealong Biotechnology headquartered?
Sealong Biotechnology is headquartered in Bengbu, China.
-
What is the size of Sealong Biotechnology?
Sealong Biotechnology has 492 total employees.
-
What industry is Sealong Biotechnology in?
Sealong Biotechnology’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Sealong Biotechnology a private or public company?
Sealong Biotechnology is a Private company.
-
What is the current valuation of Sealong Biotechnology?
The current valuation of Sealong Biotechnology is .
-
What is Sealong Biotechnology’s current revenue?
The current revenue for Sealong Biotechnology is .
-
How much funding has Sealong Biotechnology raised over time?
Sealong Biotechnology has raised $52.3M.
-
Who are Sealong Biotechnology’s investors?
Founder Hesheng Investment, Anhui Fubo Pharmaceutical and Chemical, Financial Street Securities, Guoyuan Securities, and Huaan Securities have invested in Sealong Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
